International Biotechnology Trust plc
Share this pagePrint this page

Portfolio Analysis

31 May 2015

Summary

 

IBT Portfolio NAV (m)

256

Number of Portfolio Companies

89

Quoted Investments

63

Unquoted Investments

26

 

Quoted / Unquoted Split
NAV by Geography

Quoted

93%

United States / Canada

90%

Unquoted

7%

Europe

10%

Total

100% 

Total

100%

 

 

 

 

 

NAV by Subsector
NAV by Market Capitalisation

 

 

Therapeutics

82%

Large-Cap (>$10bn)

59%

Medical Devices

3%

Mid-Cap (>$1bn, <$10bn)

18%

Specialty Pharma

12%

Small-Cap (<$1bn)

16%

Life Sciences, Tools

3%

Unquoted

7%

Total100%

Total

100%

 

 

NAV by Development Phase
NAV by Portfolio Profitability

 

 

 

Marketed

59%

Profitable

54%

Regulatory

13%

Turning Profitable 2014

6%

Phase 3

17%

Unprofitable

40%

Phase 2

7%

Total

100%

Phase 1

1%

 

Other

3%

 

Total

100%